Hologic (HOLX) Reports In-Line Q2 EPS; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Hologic Announces Financial Results for Second Quarter of Fiscal 2020
April 29, 2020 4:01 PM EDTRevenue of $756.1 Million Declines 7.6% due to Cynosure Divestiture, 7.1% in Constant Currency
Organic Revenue Increases 0.5%, 1.1% in Constant Currency
Company Posts GAAP Diluted EPS of $0.36, Non-GAAP Diluted EPS of $0.57
Company to Introduce Second High-Throughput Coronavirus Test for Panther® Platform
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal second quarter ended March 28, 2020.
Our second quarter revenue results reflect the strong underlying momentum that has been building at Hologic over the last... More
